ArchiMed overview
Stories about ArchiMed
From hype to reality: continuation funds bear fruit for LPs
A recent continuation fund exit by TPG is further evidence that such vehicles can reward investors with the capacity and desire to roll over, or those who opt to back funds investing in these deals.
ARCHIMED beats target with €3.5bn healthcare fund
The healthcare-focused firm has more than doubled its firepower for its latest buy-and-build-focused vehicle.
ArchiMed scores 300x return for debut fund with Polyplus exit
ArchiMed and Warburg Pincus have agreed to sell the France-headquartered business to life science group Sartorius for approximately €2.4bn.
France's ArchiMed: Everybody wants to get into healthcare
We catch up with chairman Denis Ribon, whose firm raised €1bn for its largest healthcare fund last year, to discuss the firm’s US expansion and competition in the mid-market.
Side Letter: Giant Australian PE portfolio sale, Dyal fundraising, how to write a pitch deck
More detail on Aussie Future Fund's multi-billion PE portfolio sale. Plus: Dyal's fundraising prowess; Archimed's US expansion; ILPA gets out to vote; and how to write a pitch deck. Here's today's brief, for our valued subscribers only.
ArchiMed sets sights on US with its largest healthcare fund
The firm held a final close on €1bn for its third fund – Europe’s largest healthcare vehicle – in late August.
Sideletter: LACERS on liquidity; emotions in PE; 44x for ArchiMed
How does it feel to work in PE? Joyous and stressful. Plus: a supercharged healthcare exit in the mid-market and LACERS on the steep rise in capital calls. Here’s today's brief, for our valued subscribers only.
ArchiMed contact information
Offices
Silex2 20F, 9 rue des Cuirassiers, Lyon, 69003, FranceContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. Edward Hallett | Job titleDirector, Investor Relations and Co-Investment | LocationLyon, France | Email  ------ |
| Key ContactMr. Baptiste Mélinon | Job titlePartner and Head of Investor Relations | LocationLyon, France | Email ------ |
| Ms. Emmanuelle Habert | Job titleChief Financial Officer | LocationLyon, France | Email ------- |
| Mr. André-Michel Ballester | Job titleManaging Partner | LocationLyon, France | Email --------- |
ArchiMed funds managed
Funds in market: 1
| Fund | Fund size | Open date | Strategy |
|---|---|---|---|
Fund size ----------- | Open dateJan 2026 | Strategy ------ | |
Closed funds: 10
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size --------- | Close dateJul 2026 | Strategy ----------- | |
Fund size ------- | Close dateApr 2024 | Strategy ----- | |
Fund size ------ | Close dateJun 2023 | Strategy ------ | |
Stories that mention ArchiMed
Industry consolidation will lead to more spin-outs to back – Unigestion
The hunger and entrepreneurship of private equity professionals shouldn't be underestimated, global head of primary fund investments Kim Pochon tells PEI.
Why spin-outs could be the future of first-time funds
There are multiple reasons why spin-out teams are uniquely positioned to overcome hurdles facing first-time fund managers, writes Karl Adam, a partner at placement agent and advisory firm Monument Group.
Side Letter: Delaying your next raise
A fundraising expert is urging GPs to avoid the temptation to launch their next vintage too early. Plus: Hamilton Lane's evergreen capital is soaring; and why impact investing is being hindered Down Under. Here's today's brief, for our valued subscribers only.
Three key trends in healthcare
Fundraising for healthcare vehicles increased markedly in 2023 as PE firms continued to back businesses across a range of verticals.
PEI Awards 2023: EMEA winners
CVC Capital partners scoops five awards, including, for the first time, lender of the year.
What to expect from APAC private equity in 2024
GP stakes, healthcare and Middle Eastern investors will be front of mind for Asia-Pacific markets in 2024.
Continuation funds continue their streak: Story of the Year
In 2023, continuation funds spread to geographic markets anew and niche strategies such as impact funds, while increasingly involving complex situations and assets.
Side Letter: LPs desire debt
Thursday is Thanksgiving for our readers in the US, so we'll return to your inboxes on Monday. In the meantime, private debt's rising appeal may come at the expense of private equity allocations. Plus: why UK dealmaking could be set to explode. Here's today's brief, for our valued subscribers only.